A prospective, single-arm, phase II clinical trial of intraoperative radiotherapy using a low-energy X-ray source for local advanced Laryngocarcinoma (ILAL): a study protocol

Abstract

Background: Laryngocarcinoma (LC), in most cases a squamous cell carcinoma, accounts for 1~5% of the incidence of all tumors. At present, laryngocarcinoma is mainly managed with the integration of surgery and radioand chemo-therapies. The current development trend of treatment is to improve the local control rate of tumor and the quality of life of patients. Intraoperative radiation therapy (IORT) is a radiotherapy that delivers single high dose irradiation at a close range to the tumor bed during the surgical operation process. It has particular radiobiological advantages in protecting normal surrounding tissues by directly applying the irradiation dose to the high-risk tumor bed area. Two forms of IORT, i.e., high dose rate (HDR) brachytherapy and external beam radiotherapy (EBRT, including electron and photono IORT), had been studied before the treatment of head and neck tumors (including laryngocarcinoma). However, no relevant assessment had been carried out on 50KV low-energy X-ray. We are convinced by certain arguments that the application of low-energy X-ray for intraoperative local radiotherapy of laryngocarcinoma can not only achieve the therapeutic effect of IORT but also reduce the incidence of high-energy irradiation related toxic and side effects. The purpose of this study is to observe the safety and short-term efficacy of IORT when used in conjunction with standard of care for the treatment of local advanced laryngocarcinoma (LAL).

Novel defined N7-methylguanosine modification-related lncRNAs for predicting the prognosis of laryngeal squamous cell carcinoma

“…One of the most prevalent forms of cancers of the head and neck is laryngeal cancer, and more than 95% of cases are laryngeal squamous cell carcinomas (LSCC) (Dong et al, 2020). One to five percent of all tumors are laryngeal cancers, & their mortality and morbidity are rising (Li et al, 2016;Yang et al, 2020). Hoarseness is a possible early symptom of LSCC, but it is not specific and is often ignored (Chen et al, 2019;Groome et al, 2003).…”

Clinical benefits of intraoperative radiotherapy for the recurrence of centrally located hepatocellular carcinoma with microvascular invasion

“…The most significant advantage of IORT is that it imparts a lower radiation hazard to other organs, such as the bowel. Recent studies have demonstrated that IORT is effective in treating breast cancer, 12 head and neck cancer 13 and thymoma. 14 However, IORT requires further exploration in liver cancer.…”

Effect of Laser Vocal Cord Surgery under Laryngeal Microscope Combined with Nano-silver Dressing Antibacterial Nursing on Efficacy and Quality of Life of Patients with Laryngeal Cancer

“…Currently, the etiology of laryngeal cancer isn't clear, but it is possibly related to smoking, air pollution, drinking, endocrine disorders, etc. (5,6). At present, the treatment of laryngeal cancer mainly includes surgery, radiotherapy, chemotherapy, and laser therapy.…”